Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04NKJ
|
|||
| Drug Name |
Alferon LDO
|
|||
| Synonyms |
LDO
Click to Show/Hide
|
|||
| Drug Type |
Protein/peptide drug
|
|||
| Indication | Severe acute respiratory syndrome (SARS) [ICD-11: 1D65] | Discontinued in Phase 2 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00215826) Study of Alferon LDO (Low Dose Oral) in Normal Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.